Modal Title

Modal Description

Bird & Bird advised Biomemory on its €17 million fundraising round

Published

Dec 23 2024

Related

Practices

Sectors

Countries

International law firm Bird & Bird advised Biomemory, a French deeptech pioneer in DNA data storage, on its €17 million Series A funding round, with new investors Crédit Mutuel Innovation, Blast.club, Bpifrance, Sorbonne Venture and Adnexus, and its existing shareholders.

Founded in 2021, this innovative deeptech spin-off from CNRS/Sorbonne University’s first objective is to produce DNA printers that can transform binary information into AGTC information (the four types of DNA nucleotide).

Two years after a €5 million seed round, Biomemory plans to use this new funding to expand its team by recruiting promising talent in molecular biology and engineering to accelerate product development and commercialisation. 

The Bird & Bird team advising on the deal consisted of lead partner Félicien Bardsley and associate Céline Sol. 

News & Deals

More News & Deals
Deal Bird & Bird advises Cheyne Capital on the acquisition of two Buxton Hotels with Champneys

Dec 10 2025

Read More
Deal Bird & Bird advises AFYREN on a €23m capital increase

Dec 09 2025

Read More
News Bird & Bird announces partnership with vibe-coding app development platform Betty Blocks

Dec 05 2025

Read More
Deal Bird & Bird advises Natural Power on strategic acquisition of renerco plan consult

Dec 04 2025

Read More
Deal Bird & Bird advises Cosmobilis Group on its strategic partnership with Macif

Dec 03 2025

Read More
Deal Bird & Bird advises Afrigreen on a €15m financing for SolarX

Dec 02 2025

Read More
More News & Deals

Related capabilities

Corporate Venture Capital Technology & Communications Life Sciences and Healthcare